Oral administration of plumbagin is beneficial in in vivo models of Duchenne muscular dystrophy through control of redox signaling

Davide Cervia, Silvia Zecchini, Luca Pincigher, Paulina Roux-Biejat, Chiara Zalambani, Elisabetta Catalani, Alessandro Arcari, Simona Del Quondam, Kashi Brunetti, Roberta Ottria, Sara Casati, Claudia Vanetti, Maria Cristina Barbalace, Cecilia Prata, Marco Malaguti, Silvia Rosanna Casati, Laura Lociuro, Matteo Giovarelli, Emanuele Mocciaro, Sestina Falcone, Claudio Fenizia, Claudia Moscheni, Silvana Hrelia, Clara De Palma, Emilio Clementi, Cristiana Perrotta

Open source

DOI
10.1016/j.freeradbiomed.2024.09.037
Published
2024-11
Container
Free Radical Biology and Medicine
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.freeradbiomed.2024.09.037,
  title = {Oral administration of plumbagin is beneficial in in vivo models of Duchenne muscular dystrophy through control of redox signaling},
  author = {Davide Cervia and Silvia Zecchini and Luca Pincigher and Paulina Roux-Biejat and Chiara Zalambani and Elisabetta Catalani and Alessandro Arcari and Simona Del Quondam and Kashi Brunetti and Roberta Ottria and Sara Casati and Claudia Vanetti and Maria Cristina Barbalace and Cecilia Prata and Marco Malaguti and Silvia Rosanna Casati and Laura Lociuro and Matteo Giovarelli and Emanuele Mocciaro and Sestina Falcone and Claudio Fenizia and Claudia Moscheni and Silvana Hrelia and Clara De Palma and Emilio Clementi and Cristiana Perrotta},
  year = {2024},
  journal = {Free Radical Biology and Medicine},
  doi = {10.1016/j.freeradbiomed.2024.09.037},
  url = {https://doi.org/10.1016/j.freeradbiomed.2024.09.037}
}

RIS

TY  - JOUR
TI  - Oral administration of plumbagin is beneficial in in vivo models of Duchenne muscular dystrophy through control of redox signaling
AU  - Davide Cervia
AU  - Silvia Zecchini
AU  - Luca Pincigher
AU  - Paulina Roux-Biejat
AU  - Chiara Zalambani
AU  - Elisabetta Catalani
AU  - Alessandro Arcari
AU  - Simona Del Quondam
AU  - Kashi Brunetti
AU  - Roberta Ottria
AU  - Sara Casati
AU  - Claudia Vanetti
AU  - Maria Cristina Barbalace
AU  - Cecilia Prata
AU  - Marco Malaguti
AU  - Silvia Rosanna Casati
AU  - Laura Lociuro
AU  - Matteo Giovarelli
AU  - Emanuele Mocciaro
AU  - Sestina Falcone
AU  - Claudio Fenizia
AU  - Claudia Moscheni
AU  - Silvana Hrelia
AU  - Clara De Palma
AU  - Emilio Clementi
AU  - Cristiana Perrotta
PY  - 2024
JO  - Free Radical Biology and Medicine
DO  - 10.1016/j.freeradbiomed.2024.09.037
UR  - https://doi.org/10.1016/j.freeradbiomed.2024.09.037
ER  - 

APA

Cervia, D., Zecchini, S., Pincigher, L., Roux-Biejat, P., Zalambani, C., Catalani, E., Arcari, A., Quondam, S. D., Brunetti, K., Ottria, R., Casati, S., Vanetti, C., Barbalace, M. C., Prata, C., Malaguti, M., Casati, S. R., Lociuro, L., Giovarelli, M., Mocciaro, E., Falcone, S., Fenizia, C., Moscheni, C., Hrelia, S., Palma, C. D., Clementi, E., & Perrotta, C. (2024). Oral administration of plumbagin is beneficial in in vivo models of Duchenne muscular dystrophy through control of redox signaling. Free Radical Biology and Medicine. https://doi.org/10.1016/j.freeradbiomed.2024.09.037

Source records